These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31494293)

  • 21. Engineering tumor cell targeting in nanoscale amyloidal materials.
    Unzueta U; Seras-Franzoso J; Céspedes MV; Saccardo P; Cortés F; Rueda F; Garcia-Fruitós E; Ferrer-Miralles N; Mangues R; Vázquez E; Villaverde A
    Nanotechnology; 2017 Jan; 28(1):015102. PubMed ID: 27893441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury.
    Luo L; Zang G; Liu B; Qin X; Zhang Y; Chen Y; Zhang H; Wu W; Wang G
    Theranostics; 2021; 11(16):8043-8056. PubMed ID: 34335979
    [No Abstract]   [Full Text] [Related]  

  • 23. Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.
    Rueda F; Céspedes MV; Sánchez-Chardi A; Seras-Franzoso J; Pesarrodona M; Ferrer-Miralles N; Vázquez E; Rinas U; Unzueta U; Mamat U; Mangues R; García-Fruitós E; Villaverde A
    Microb Cell Fact; 2016 Apr; 15():59. PubMed ID: 27059706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs.
    Sánchez-García L; Serna N; Álamo P; Sala R; Céspedes MV; Roldan M; Sánchez-Chardi A; Unzueta U; Casanova I; Mangues R; Vázquez E; Villaverde A
    J Control Release; 2018 Mar; 274():81-92. PubMed ID: 29408658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
    Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
    Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tat/HA2 Peptides Conjugated AuNR@pNIPAAm as a Photosensitizer Carrier for Near Infrared Triggered Photodynamic Therapy.
    Ye S; Kang N; Chen M; Wang C; Wang T; Wang Y; Liu Y; Li D; Ren L
    Mol Pharm; 2015 Jul; 12(7):2444-58. PubMed ID: 26031331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of targeted protein nanoparticles from functional bacterial amyloids: A death star-like approach.
    Unzueta U; Cespedes MV; Sala R; Alamo P; Sánchez-Chardi A; Pesarrodona M; Sánchez-García L; Cano-Garrido O; Villaverde A; Vázquez E; Mangues R; Seras-Franzoso J
    J Control Release; 2018 Jun; 279():29-39. PubMed ID: 29641987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4
    Cano-Garrido O; Álamo P; Sánchez-García L; Falgàs A; Sánchez-Chardi A; Serna N; Parladé E; Unzueta U; Roldán M; Voltà-Durán E; Casanova I; Villaverde A; Mangues R; Vázquez E
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanostructured toxins for the selective destruction of drug-resistant human CXCR4
    Serna N; Álamo P; Ramesh P; Vinokurova D; Sánchez-García L; Unzueta U; Gallardo A; Céspedes MV; Vázquez E; Villaverde A; Mangues R; Medema JP
    J Control Release; 2020 Apr; 320():96-104. PubMed ID: 31931052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering of a tumor cell-specific, cytosol-penetrating antibody with high endosomal escape efficacy.
    Kim JS; Park JY; Shin SM; Park SW; Jun SY; Hong JS; Choi DK; Kim YS
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2510-2516. PubMed ID: 30208519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Tumor Hypoxia Using Nanoparticle-engineered CXCR4-overexpressing Adipose-derived Stem Cells.
    Jiang X; Wang C; Fitch S; Yang F
    Theranostics; 2018; 8(5):1350-1360. PubMed ID: 29507625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cationized dextran nanoparticle-encapsulated CXCR4-siRNA enhanced correlation between CXCR4 expression and serum alkaline phosphatase in a mouse model of colorectal cancer.
    Abedini F; Hosseinkhani H; Ismail M; Domb AJ; Omar AR; Chong PP; Hong PD; Yu DS; Farber IY
    Int J Nanomedicine; 2012; 7():4159-68. PubMed ID: 22888250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of CXCR3 and CXCR4 in colorectal cancer metastasis.
    Murakami T; Kawada K; Iwamoto M; Akagami M; Hida K; Nakanishi Y; Kanda K; Kawada M; Seno H; Taketo MM; Sakai Y
    Int J Cancer; 2013 Jan; 132(2):276-87. PubMed ID: 22689289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4
    Rioja-Blanco E; Arroyo-Solera I; Álamo P; Casanova I; Gallardo A; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; Mangues R; Alba-Castellón L; León X
    Acta Pharm Sin B; 2022 May; 12(5):2578-2591. PubMed ID: 35646535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of a multicomponent peptide-woven nanocomplex for delivery of siRNA.
    Jun E; Kim S; Kim JH; Cha K; So IS; Son HN; Lee BH; Kim K; Kwon IC; Kim SY; Kim IS
    PLoS One; 2015; 10(2):e0118310. PubMed ID: 25705892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo.
    Gu X; Wei Y; Fan Q; Sun H; Cheng R; Zhong Z; Deng C
    J Control Release; 2019 May; 301():110-118. PubMed ID: 30898610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR3 expression in colorectal cancer cells enhanced invasion through preventing CXCR4 internalization.
    Jin J; Zhang Z; Wang H; Zhan Y; Li G; Yang H; Fei Z; Xu Y; Li W
    Exp Cell Res; 2018 Oct; 371(1):162-174. PubMed ID: 30092218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.